<?xml version="1.0" encoding="UTF-8"?>
<ref id="B150-pharmaceutics-12-00171">
 <label>150.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Prathipati</surname>
    <given-names>P.K.</given-names>
   </name>
   <name>
    <surname>Mandal</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Pon</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Vivekanandan</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Destache</surname>
    <given-names>C.J.</given-names>
   </name>
  </person-group>
  <article-title>Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice Model</article-title>
  <source>Pharm. Res.</source>
  <year>2017</year>
  <volume>34</volume>
  <fpage>2749</fpage>
  <lpage>2755</lpage>
  <pub-id pub-id-type="doi">10.1007/s11095-017-2255-7</pub-id>
  <?supplied-pmid 28905173?>
  <pub-id pub-id-type="pmid">28905173</pub-id>
 </element-citation>
</ref>
